206 related articles for article (PubMed ID: 3132518)
1. [Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
Wada H; Suzuki H; Mori Y; Deguchi A; Oukubo I; Tsuda M; Tanaka I; Deguchi K; Shirakawa S; Minami N
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):67-73. PubMed ID: 3132518
[No Abstract] [Full Text] [Related]
2. Gabexate as a therapy for disseminated intravascular coagulation.
Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of pre-disseminated intravascular coagulation state with gabexate mesilate (FOY)].
Wada H; Suzuki H; Deguchi A; Mori Y; Okubo I; Tsuda M; Nagano T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1986 Dec; 27(12):2243-8. PubMed ID: 3106677
[No Abstract] [Full Text] [Related]
4. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
Taenaka N; Shimada Y; Hirata T; Nishijima MK; Takezawa J; Yoshiya I; Kambayashi J
Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
[TBL] [Abstract][Full Text] [Related]
5. [Effects of FOY on DIC patients associated with hematological neoplastic disorders. Hanshin Cooperative Study Group of Hematological Disorders].
Taniguchi N; Kitani T; Kawagoe H; Horiuchi A; Masaoka T; Yasunaga K; Okamoto Y; Ohkubo A; Yonezawa T; Nagai K
Rinsho Ketsueki; 1987 Oct; 28(10):1729-37. PubMed ID: 3133506
[No Abstract] [Full Text] [Related]
6. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
[TBL] [Abstract][Full Text] [Related]
7. Abdominal aortic aneurysm complicated with chronic disseminated intravascular coagulopathy: a case of surgical treatment.
Mukaiyama H; Shionoya S; Ikezawa T; Kamiya T; Hamaguchi M; Saito H
J Vasc Surg; 1987 Dec; 6(6):600-4. PubMed ID: 3121870
[TBL] [Abstract][Full Text] [Related]
8. Treatment of disseminated intravascular coagulation with gabexate mesilate.
Tamaki S; Wada H; Hiyoyama K; Shimura M; Minamikawa K; Wakita Y; Nakase T; Ohiwa M; Kaneko T; Iwasaki E
Clin Ther; 1993; 15(6):1076-84. PubMed ID: 8111805
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of FOY therapy for DIC or pre-DIC associated with neurosurgical disease].
Wakui K; Takemae T; Kobayashi S
No Shinkei Geka; 1990 Jul; 18(7):609-17. PubMed ID: 2118601
[TBL] [Abstract][Full Text] [Related]
10. [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
Satokawa H; Iwaya F; Igari T; Abe T; Hagiwara K; Tanji M; Watanabe M; Midorikawa H; Sato Y; Takase S
Kyobu Geka; 1990 Apr; 43(4):271-5. PubMed ID: 2112659
[TBL] [Abstract][Full Text] [Related]
11. Studies on the effects of primary therapy for DIC following circulatory arrest.
Takemoto Y; Tanaka S; Tanabe J; Nakamura Y; Kohama A; Shibata S
Am J Hematol; 1986 Apr; 21(4):377-82. PubMed ID: 3082185
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of gabexate mesilate (FOY) on experimental DIC.
Isobe J
Adv Exp Med Biol; 1979; 120B():385-94. PubMed ID: 229708
[TBL] [Abstract][Full Text] [Related]
13. [Synthetic protease inhibitors in the treatment of disseminated intravascular coagulation].
Aramoto H; Saito H; Shigematsu H; Muto T
Nihon Rinsho; 1993 Jan; 51(1):93-8. PubMed ID: 8433532
[TBL] [Abstract][Full Text] [Related]
14. Disseminated intravascular coagulation after hepatic resection.
Tsuzuki T; Toyama K; Nakayasu K; Iida S; Ueda M; Toizumi A
Surgery; 1990 Feb; 107(2):172-6. PubMed ID: 2154054
[TBL] [Abstract][Full Text] [Related]
15. [Disseminated intravascular coagulation (DIC) following open heart surgery and great vessel surgery. The result of early administration of gabexate mesilate (FOY)].
Chihara K; Akiyama F; Shinozaki T; Shimamoto M; Takahashi K; Imura H; Yamazaki F; Kawarazaki S
Kyobu Geka; 1984 Aug; 37(8):606-13. PubMed ID: 6438381
[No Abstract] [Full Text] [Related]
16. [Treatment of disseminated intravascular coagulation].
Asakura H
Rinsho Ketsueki; 1990 Jun; 31(6):756-62. PubMed ID: 2214166
[TBL] [Abstract][Full Text] [Related]
17. [Thoracic aortic aneurysm with chronic disseminated intravascular coagulation treated successfully with orally administered camostat mesilate, warfarin and aspirin].
Fukuda N; Shimohakamada Y; Nakamori Y; Tominaga T; Shinohara K; Takahashi T; Oeda E; Sato Y
Rinsho Ketsueki; 2002 Mar; 43(3):199-203. PubMed ID: 11979753
[TBL] [Abstract][Full Text] [Related]
18. [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm].
Yoneda K; Amano I; Tanaka H; Yagi H; Tsukaguchi N; Morii T; Narita N
Rinsho Ketsueki; 2001 Jan; 42(1):30-4. PubMed ID: 11235131
[TBL] [Abstract][Full Text] [Related]
19. [Protection of endotoxin-induced disseminated intravascular coagulation in rats by gabexate mesilate].
Yoshikawa T; Furukawa Y; Murakami M; Takemura S; Kondo M
Nihon Ketsueki Gakkai Zasshi; 1982 May; 45(3):633-40. PubMed ID: 6814144
[No Abstract] [Full Text] [Related]
20. [Anti DIC therapy].
Yahata M; Sakamoto Y
Nihon Rinsho; 2016 Feb; 74(2):257-61. PubMed ID: 26915249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
